MINNEAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Bio-Techne (TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced ...
--Bio-Techne Corporation, a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay for in situ ...
Partnership strengthens Bio-Techne's (TECH) leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities for advanced research and diagnostics ...
Bio-Techne proteins are the most cited proteins in scientific literature. We do not think this is a trivial data point because there are few regulations on third-party protein quality, and customers ...
Hosted on MSN
Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance
CEO Kim Kelderman highlighted 6% organic revenue growth amidst a challenging macro environment. Key drivers included strength in core reagents, automated analytical solutions, and cell and gene ...
Bio-Techne proteins are the most cited proteins in scientific literature. We do not think this is a trivial data point because there are few regulations on third-party protein quality, and customers ...
May 7 (Reuters) - Bio-Techne (TECH.O), opens new tab on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other ...
Bio-Techne’s TECH GMP reagents, including GMP proteins and small molecules, remain a cornerstone of its cell therapy offering. Acquisitions have continued to play an important role in the company’s ...
More than 600,000 times, researchers have cited Bio-Techne Corp. in academic papers as a manufacturer of tools that helped in their search for new tests and treatments. The company, Minnesota's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results